National Science, Technology, and Innovation Policy (NSTIP) 2020–2040 Draft (DST)
๐ Tailored for UPSC GS Paper III, Essay, and Prelims
๐งท 1. Overview
| Feature | Biotech Vision 2030 | National STI Policy 2020 |
|---|---|---|
| ๐งพ Published by | NITI Aayog + Department of Biotechnology (DBT) | Department of Science and Technology (DST) |
| ๐ Timeframe | Till 2030 | Till 2040 |
| ๐ฏ Primary Focus | Building a bioeconomy through biotech innovation | Reforming India's entire S&T ecosystem |
| ๐งฌ Core Domain | Health, agriculture, industrial biotech, environment | All areas of science, research & innovation |
๐ 2. Goals & Vision
| Theme | Biotech Vision 2030 | NSTIP 2020 |
|---|---|---|
| ๐ฏ Vision | Position India among top 5 global bio-innovation nations | Make India a global science & innovation leader by 2040 |
| ๐ฐ Economy Target | $150 billion bioeconomy | 2% of GDP to be spent on R&D |
| ๐งช Innovation Focus | Synthetic biology, CAR-T, biomanufacturing | Open science, citizen science, AI, frontier tech |
| ๐️ Infrastructure | 30+ biotech parks, shared labs, BSL-3/4 labs | National Research Foundation (NRF), research clusters |
๐ฅ 3. Inclusivity & Access
| Area | Biotech 2030 | NSTIP 2020 |
|---|---|---|
| ๐ง๐พ Rural Focus | Biotech KISAN, agri-bio startups | Expand science outreach in rural India |
| ๐ฉ Women in STEM | Bioentrepreneurship for women | 30% representation in decision-making roles |
| ๐ Open Access | Less emphasis | Strong focus on open data, open access |
๐️ 4. Regulation & Funding
| Parameter | Biotech Vision 2030 | NSTIP 2020 |
|---|---|---|
| ๐งพ Regulation | Fast-track biotech approvals, ethics for gene therapy | Integrated regulatory framework across ministries |
| ๐ธ Funding Model | BIRAC, public-private co-investment | R&D increase via public-private partnerships + CSR |
| ๐ IPR Focus | Stronger biotech IP regime | Inclusive IP policy and innovation valuation system |
๐ 5. Technology Domains
| Sector | Biotech Vision 2030 | NSTIP 2020 |
|---|---|---|
| ๐งฌ Health | CAR-T, vaccine R&D, bioinformatics | Genomics, personalised medicine, AI diagnostics |
| ๐พ Agriculture | CRISPR crops, bio-inputs | Soil, seed, climate tech |
| ๐งซ Environment | Waste-to-energy, bioplastics | Sustainability, climate innovation, green energy |
| ๐ค AI Integration | AI in protein design, genome research | AI in all scientific workflows & decision systems |
⚖️ 6. Institutional Support
| Component | Biotech 2030 | NSTIP 2020 |
|---|---|---|
| ๐งฌ Lead Agency | DBT | DST |
| ๐ค PPP Support | BIRAC | NRF + DST schemes |
| ๐ก Innovation Hubs | BioNEST, Biotech Parks | Science Cities, Atal Innovation Mission linkage |
| ๐ Data Ecosystem | Genomics and lab integration | National STI Observatory, real-time policy dashboard |
๐ง 7. Skill Development
| Biotech Vision 2030 | NSTIP 2020 |
|---|---|
| Target: 1 million biotech professionals | Cross-disciplinary training, innovation fellowships |
| Hands-on biotech manufacturing skills | Coding, scientific writing, research ethics |
๐ Summary Table: Key Differences
| Area | Biotech Vision 2030 | NSTIP 2020 |
|---|---|---|
| Sector | Niche (biotech only) | Holistic (all sciences) |
| Timeframe | 2020–2030 | 2020–2040 |
| Output Goal | $150B bioeconomy | 2% GDP R&D spend |
| R&D Infra | Biotech parks, BSL labs | National Research Foundation |
| Ethics | Gene therapy, biosafety | Open science, inclusive ethics |
| Launch Body | DBT + NITI Aayog | DST |
๐งพ UPSC Prelims Possible Questions
Q. Which of the following are features of Biotech Vision 2030?
Promotion of CRISPR crops
Creation of a National Research Foundation
Development of bio-manufacturing hubs
Correct Code:
(a) 1 and 3 only ✅
(b) 2 and 3 only
(c) 1 and 2 only
(d) All of the above
๐ Explanation: National Research Foundation is from NSTIP, not Biotech Vision.
✍️ Use in Mains / Essay
GS Paper III
-
“Policy efforts for R&D and innovation in India”
-
“Biotech and AI: Building the future economy”
Essay Topics
-
“India’s Tryst with Innovation: From Labs to Lives”
-
“Science and Society: Bridging Innovation and Inclusion”
No comments:
Post a Comment